Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients

BACKGROUND: Severe coronavirus disease 2019 (COVID‐19) is characterized by marked hypoxaemia and lung oedema, often accompanied by disordered blood coagulation and fibrinolytic systems, endothelial damage and intravascular fibrin deposition. PATIENTS/METHODS: We present a retrospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardiner, Chris, Mackie, Ian J., MacCallum, Peter, Platton, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111592/
https://www.ncbi.nlm.nih.gov/pubmed/35451557
http://dx.doi.org/10.1111/ijlh.13855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111592/
https://www.ncbi.nlm.nih.gov/pubmed/35451557
http://dx.doi.org/10.1111/ijlh.13855

Ejemplares similares